Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Midwife-Led class improve sex and online health skills after menopause?

NCT ID NCT07839416

Symptom relief Sponsor: Kahramanmaras Sutcu Imam University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 24, 2026 · Last updated Sep 25, 2026 · Updated 1 time

Summary

Researchers are testing whether a midwife-led education program improves sexual function and digital health literacy in postmenopausal women aged 45 to 60. The program combines one in-person session with two online sessions over three weeks, covering sexual health during menopause, pelvic floor exercises, partner communication, and skills for finding reliable online health information. Half of the 128 participants receive the education, while the other half continue with usual care. Both groups complete questionnaires before and after the program so researchers can compare changes in sexual function and digital health literacy.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A midwife-led hybrid health literacy education program delivered through one in-person session and two online sessions
What this could lead to
If it works, this could give clinics a low-cost, midwife-led way to help postmenopausal women manage sexual concerns and find trustworthy health information online.
What could go wrong
This is a small, single-center study of 128 women in Türkiye, so results may not apply elsewhere. Self-reported questionnaires can be influenced by expectations, and the program may not change long-term habits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 128 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 to 60 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women aged 45-60 years. Postmenopausal status, defined as at least 12 months since the last menstrual period. Willing and able to provide written informed consent. Able to use a smartphone, tablet, or computer and participate in online sessions. Able to read and write in Turkish. Exclusion Criteria: * Serious systemic disease, such as heart failure, renal failure, liver failure, or uncontrolled hypertension. A diagnosis of depression, an anxiety disorder, dementia, or another serious psychiatric condition. A history of pelvic surgery or a current vaginal infection. Current use of hormone therapy. Regular use of medications that may affect sexual function, such as antidepressants.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Digital health literacy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Digital health literacy Health literacy Postmenopause Sexual function

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Kahramanmaraş Sütçü İmam Universty

    Kahramanmaraş, Kahramanmaraş, 46100, Turkey (Türkiye)

  • Kahramanmaraş Sütçü İmama Universty

    Kahramanmaraş, Kahramanmaraş, 46100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.